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REGULATION OF STEM CELL RESEARCH: A
RECOMMENDATION THAT THE UNITED STATES
ADOPT THE AUSTRALIAN APPROACH
Bryn E. Floyd
Abstract: Research using embryonic stem cells may lead to great medical
advances because of their ability to differentiate into nearly any type of human tissue.
Currently, the United States regulates embryonic stem cell research by limiting the stem
cell lines that can be studied using federal money or by scientists working at federally-
funded institutions. The states are left to regulate privately funded research, if they
choose. This creates a situation in which federally-funded research is severely limited,
while private funds may be used to conduct ethically problematic research.
In contrast, the Australian Parliament has passed legislation regulating embryonic
stem cell research and limiting the sources of new stem cell lines to embryos originally
created for infertility treatments but beyond the needs of the person or couple being
treated. The Australian laws outline the informed consent procedure required before
excess embryos can be donated and set up a regulatory framework to ensure that stem
cell research is conducted ethically.
The United States should follow Australia's lead and pass legislation that would
allow federally-funded researchers to derive new embryonic stem cell lines from excess
embryos left over after infertility treatments. This system reaches a compromise between
those who oppose stem cell research and those who believe it should be fully supported
because of the enormous potential for new medical treatments. Passing legislation
similar to Australia's will allow the United States to explore the potential medical
benefits of stem cell research, while avoiding the ethical dilemmas that arise when
researchers are allowed to create cloned embryos for the sole purpose of deriving new
stem cell lines.
I. INTRODUCTION
When researchers derived the first embryonic stem cells in November
1998, the public and most of the scientific community were caught off
guard.' The announcement that human stem cells could be isolated offered
great promise for scientific advances, but also gave rise to serious
controversy over the ethics of creating human embryos solely for research
purposes and then destroying them to obtain stem cells. Ethicists,
researchers, religious scholars, legislators, and the general public have
1 THE HUMAN EMBRYONIC STEM CELL DEBATE: SCIENCE, ETHICS, AND PUBLIC POLICY xv
(Suzanne Holland et al. eds., 2001) [hereinafter THE HUMAN EMBRYONIC STEM CELL DEBATE].
2 Id. The debate runs along a continuum from those who believe disease treatments that may result
from stem cell research justify the creation of embryos for the purpose of using them to derive stem cells to
those who believe no medical benefits could possibly justify the destruction of an embryo to obtain stem
cells, even if that embryo will otherwise be discarded.
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joined in the debate.3 Deeply held beliefs and scientific uncertainties make
resolution of the controversy difficult, though not impossible.
4
Meanwhile, millions of patients in the United States and worldwide
suffer from diseases that might one day be remedied by treatments resulting
from stem cell research.5 In order to maximize the availability of potential
treatments, however, stem cell researchers must have access to genetically
diverse stem cell lines 6 and adequate funding sources.
Yet the United States' current legislative scheme fails to address these
needs. In the United States, federally-funded stem cell research is limited to
using the few stem cell lines that were derived, prior to August 9, 2001, from
excess embryos intended for us in in vitro fertilization.7 Because the federal
government 8 is a major source of medical research funding, this approach
severely inhibits stem cell research in the United States,9 and prevents full
realization of the benefits of stem cell research.' 0 Furthermore, the genetic
diversity of these stem cell lines is extremely limited." The federal
government, however, does not place restrictions on the sources from which
stem cells can be derived using private funds. 12 That is left to the states.
3 For examples of different perspectives on the debate see id; NATIONAL BIOETHICS ADVISORY
COMM'N, ETHICAL ISSUES IN HUMAN STEM CELL RESEARCH: COMMISSIONED PAPERS 11 (2000); CENTER
FOR BIOETHICS AND HUMAN DIGNITY, ON HUMAN EMBRYOS AND STEM CELL RESEARCH: AN APPEAL FOR
ETHICALLY RESPONSIBLE SCIENCE AND PUBLIC POLICY (1999), at
http://www.cbhd.org/resources/stemcells/position_statement.htm (last visited June 6, 2003).
4 George J. Annas, et al., Stem Cell Politics, Ethics and Medical Progress, 5 NATURE MED. 1339
(1999). Daniel Perry, Patients Voices: The Powerful Sound in the Stem Cell Debate, 287 SCIENCE 1423
(2000). Perry cites data from the Patient's Coalition for Urgent Research showing 128.4 million patients in
the United States suffering from diseases that may be helped by stem cell research. Id. These include
cardiovascular diseases, autoinimune diseases, diabetes, osteoporosis, cancer, Alzheimer's disease,
Parkinson's disease, severe bums, spinal cord injuries, and birth defects. Id.
6 Sheryl Gay Stolberg, The President's Decision: The Research; U.S. Acts Quickly to Put Stem Cell
Policy in Effect, N.Y. TIMES, Aug. 11, 2001, at Al. To create effective medical treatments, researchers will
need stem cell lines that match the genetic diversity of the population. Id.
7 President George W. Bush, Remarks by the President on Stem Cell Research, Aug. 9, 2001, at
http://www.whitehouse.gov/news/releases/2001/08/20010809-2.htnl (last visited Nov. 6, 2003)
[hereinafter Remarks by the President].
8 As used in this comment, the term "federal government" will mean the United States federal
government.
9 Over the last fifty years the United States has invested far more resources in basic research than all
other nations combined. Jon D. Miller, The Future of Research; In a Squeeze; Science Advisory Boards
Get Loaded with Anti-Science, NEWSDAY, Feb. 23, 2003, at A24.
15 Stem cell research has the potential to lead to treatments that will restore failing organs and repair
injuries to the central nervous system. Thomas B. Okarma, Human Embryonic Stem Cells: A Primer on the
Technology and Its Medical Applications, in THE HUMAN EMBRYONIC STEM CELL DEBATE, supra note 1, at
3.
I Kristen Philipkoski, Bush: Too Far or Not Far Enough?, WIRED NEWS, Aug. 10, 2001, at
http://www.wired.connews/politics/0,1283,45992,00.html (last visited Nov. 6, 2003).
12 In recent years, Congress has attempted to pass legislation that would directly regulate cloning and
stem cell research in the United States whether funded by public or private money, but none of the
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In contrast to the American scheme, Australia's stem cell legislation
provides a more logical system that addresses ethical concerns and is more
likely to lead to greater medical benefits. In December 2002, the Australian
Parliament passed two laws, the Research Involving Human Embryos Act
("RIHEA") and the Prohibition of Human Cloning Act ("PHCA"). 13 These
acts were intended to prevent human cloning and to support research
involving stem cells derived from embryos that were originally created to
assist an infertile couple in becoming pregnant but were not needed by the
couple.14 These laws seek to reach a compromise between the interests of
patients who may benefit from stem cell research and those who oppose
stem cell research on moral grounds. 15  The RIHEA allows stem cell
researchers in Australia to derive new stem cell lines using government
funding, while the PHCA limits more ethically problematic sources of stem
cells, including human embryos created solely for the purpose of deriving
new cell lines.'
6
As a compromise to those who have a moral disagreement with
embryonic stem cell research, the United States should follow Australia's
lead and enact legislation to allow stem cell researchers to derive new and
diverse stem cell lines using federal funding, but limit the sources of those
new cell lines to embryos created, but no longer needed, for assisted
reproductive technology. This approach would increase the likelihood that
disease treatments will be commercially available sooner, while minimizing
the moral dilemma that arises when researchers create embryos for the sole
purpose of deriving stem cell lines.
Part II of this Comment explains the variety of stem cell sources. Part
III explores the controversies surrounding stem cell research and discusses
the benefits that may result from studying embryonic stem cells. Parts IV
and V explain the current approaches toward regulating stem cell research in
the United States and in Australia, respectively. Part VI argues that the
proposed bills have passed. Examples include: Human Cloning Ban and Stem Cell Research Protection
Act of 2002, S. 1893, 107th Cong. (2002); Stem Cell Research Act of 2001, H.R. 2059, 107th Cong.
(2001); Stem Cell Research Act of 2000, S. 2015, 106th Cong. (2000). Bills currently under consideration
include the Human Cloning Prohibition Act of 2003, H.R. 534, 108th Cong. (2003), and the Cloning
Prohibition Act of 2003, H.R. 801, 108th Cong. (2003).
13 Darren Gray, Senate Backs Use of Human Embryos in Stem Cell Research, THE AGE, Dec. 6,
2002, 2002 WL 103071091; Sandra O'Malley, Stem Cell Laws Pass Through Parliament with Little
Fanfare, AUSTRALIAN AP GEN. NEWS, Dec. 11, 2002, 2002 WL 103858390.
14 Research Involving Human Embryos Act No. 145, 2002 (Austl.); Prohibition of Human Cloning
Act, No. 144, 2002 (Austl.).
" Australia to Allow Use of Human Embryos for Stem Cell Research, TRANSPLANT NEWS, Apr. 28,
2002, LEXIS, News Group File.
16 Research Involving Human Embryos Act No. 145, 2002 (Austl.). Prohibition of Human Cloning
Act, No. 144, 2002 (Austl.).
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Australian approach is superior to the United States' because it creates a
middle ground, allowing for a more diverse supply of stem cell lines than
that permitted under federally-funded research in the United States, while
providing greater safeguards against unethical sources of stem cell lines.
Finally, Part VII recommends that the United States adopt federal legislation
similar to Australia's.
II. EMBRYOS CREATED FOR IN VITRO FERTILIZATION ARE THE MOST
FEASIBLE SOURCE OF STEM CELLS
Stem cells 17 come from a variety of sources.' Embryonic stem cells
are obtained from human embryos at a very early stage of development.'
9
They may be derived from embryos that were created through in vitro
fertilization ("IVF") 20 or through a cloning technique known as somatic cell
nuclear transfer ("SCNT").21  Embryonic germ cells 22 are derived from
embryos at a later stage of development. 23 Multipotent stem cells are found
in mature tissue.24 Another source of stem cells is the somatic cells of a
fully-formed organism. 25  Of these different sources, excess IVF embryos
are the preferred source of stem cells for medical research. This is true for
two reasons. First, they have the ability to develop into all types of human
tissues. Second, they do not present the added ethical dilemmas that arise
17 Stem cells are cells that can renew themselves in the undifferentiated state as well as give rise to
multiple types of differentiated tissue. Okarma, supra note 10, at 4. Various types of stem cells have
differing abilities to give rise to specialized descendant cells. AUDREY R. CHAPMAN ET AL., AMERICAN
ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE AND INSTITUTE FOR CIVIL SOCIETY, STEM CELL
RESEARCH AND APPLICATIONS MONITORING THE FRONTIERS OF BIOMEDICAL RESEARCH 1 (1999),
available at http://www.aaas.org/spp/sfrl/projects/stem/report.pdf (last visited Nov. 6, 2003). Cells that
have the ability to develop into a complete, functioning organism are said to be totipotent. Id. Pluripotent
stem cells are those that can differentiate into nearly any type of tissue but have lost the ability to develop
into a complete organism. Id. Multipotent stem cells have already differentiated to a certain degree and
can only give rise to a limited number of tissue types. Id.
'" CHAPMAN ET AL., supra note 17, at I.
19 Id.
20 NIH, Stem Cell Basics (2000), at http://stemcells.nih.gov/infoCenter/stemCellBasics.pdf (last
visited Nov. 6, 2003) [hereinafter Stem Cell Basics]. In vitro fertilization is a process by which a woman's
eggs are extracted and then fertilized outside of her body in a laboratory setting. Id.
2" CLONES AND CLONES: FACTS AND FANTASIES ABOUT HUMAN CLONING 31 (Martha C. Nussbaum
& Cass R. Sunstein eds., 1998). SCNT is also known as "nuclear transplantation cloning." Id.
22 Human embryonic germ cells are derived from cells in the fetus that would ordinarily develop into
eggs or sperm. NIH, Stem Cells: Scientific Progress and Future Research Directions 13 (2001), at
http://stemcells.nih.gov/stemcell/pdfs/chapter3.pdf (last visited Dec. 19, 2003).
23 CHAPMAN ETAL., supra note 17, at 1.
24 id.
25 Stem Cell Basics, supra note 20.
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when stem cells are derived from aborted fetuses or from embryos that were
created specifically for the purpose of starting a new stem cell line.
A. Human Embryonic Stem Cells Created Through In Vitro Fertilization
The embryonic stem cells used in research are derived from in vitro
fertilization.26 At fertilization, a sperm cell and an egg cell come together to
form a single cell that has the potential to develop into a complete
organism. 27 The stem cells found in an early embryo are more versatile than
stem cells found in a completely developed human being.28 In the earliest
stages of development as the fertilized egg divides and creates new cells,
each of these cells is totipotent, meaning each has the potential to form any
type of human tissue and to become a complete human being.29
After four or five days of development, the embryo is a hollow ball of
cells called a blastocyst. 30 By this stage, some of the cells have begun to
lose their unlimited differentiation potential. 31  The outer layer of cells,32known as the trophectoderm, is committed to forming placental tissues.
Embryonic stem cells are obtained by destroying the trophectoderm, and
thus the cell, and removing the inner mass of about thirty cells from the
blastocyst.
33
These cells are then cultured in a laboratory. 34 As the initial mass of
cells divides and creates new cells, the cells are placed into new culture
dishes.35 After six months of this culturing process, the original cell mass
can result in millions of pluripotent stem cells.
36
26 id.
27 Id.
2' NATIONAL BIOETHICS ADVISORY COMMISSION, ETHICAL ISSUES IN HUMAN STEM CELL
RESEARCH: REPORT AND RECOMMENDATIONS I, 7 (1999) [hereinafter NBAC REPORT AND
RECOMMENDATIONS].
29 THE HUMAN EMBRYONIC STEM CELL DEBATE, supra note 1, at xvii.
3 STEM CELLS: A PRIMER, supra note 20.
31 NBAC REPORT AND RECOMMENDATIONS, supra note 28, at 9.
32 id.
33 Stem Cell Basics, supra note 20.
34 id.
35 Id.
36 Id.
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B. Human Embryonic Germ Cells are an Undesirable Source of Stem
Cells
A less desirable source of stem cells is the gonadal ridge37 of early
fetal tissue.38 Experiments on embryonic germ cells have been limited and it
is believed that their differentiation capabilities will be more limited than
those of embryonic stem cells because they are further along in
development 39-a fact that could limit their potential use in treatments.
Because embryonic germ cells are derived from an aborted fetus, 40 they
present an added ethical dilemma.
C. Adult Stem Cells Are Also an Undesirable Source of Stem Cells
Undifferentiated cells found in developed tissue, known as adult or
somatic stem cells,4 1 are another undesirable source of stem cells. These
adult stem cells replenish cells lost naturally by the organism.42 For
example, they replace the lining of the gut, generate new skin, and produce
many different types of blood cells.43 However, because adult stem cells are
44
already partially differentiated they are therefore only multipotent. As a
result, their potential usefulness for medical research is also limited.
Moreover, because scientists do not currently know how many kinds of adult
stem cells exist,45 they are unlikely to serve as a satisfactory replacement for
embryonic stem cells.46
37 The gonadal ridge is a specific structure in an embryo, which, if allowed to develop fully, would
become the testes or ovaries of a mature human organism. NIH, Stem Cells: Scientific Progress and Future
Directions (2001) at ES-2, at http://stemcells.nih.gov/stemcell/pdfs/fulrptsterrLpdf (last visited Nov. 14,
2003).
38 THE HUMAN EMBRYONIC STEM CELL DEBATE, supra note 1, at xvii.
39 CHAPMAN ET AL., supra note 17, at 3. Embryonic germ cells are derived from fetuses aborted
after five to nine weeks of development. Id.
40 THE HUMAN EMBRYONIC STEM CELL DEBATE, supra note 1, at xvii.
41 Stem Cell Basics, supra note 20.
42 Id.
43 NBAC REPORT AND RECOMMENDATIONS, supra note 28.
44 id.
45 Stem Cell Basics, supra note 20.
46 CHAPMAN ET AL., supra note 17, at 3.
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D. Stem Cells Created by Somatic Cell Nuclear Transfer Present Ethical
Dilemmas
A fourth source of stem cells is the Somatic Cell Nuclear Transfer
("SCNT") technique, also known as nuclear transplantation cloning.47 In
this technique, the nucleus is removed from an egg and is replaced with the
nucleus of a somatic cell. 48  The resulting cell contains a full set of
chromosomes identical to that of the individual who donated the somatic
cell.49 This is the method that was used to create Dolly, the cloned sheep.5°
Using SCNT to create stem cells adds another layer to the controversy
surrounding stem cell research because it involves human cloning.
Although, the intent of stem cell researchers is merely to derive stem cells,
use of SCNT is likely to lead to public concerns that researchers will take
the next step and attempt to create a fully-formed human clone.
In addition to the ethical problems presented by using a cloning
technique, SCNT is technically more difficult than creating an embryo
through IVF. 51 Furthermore, like IVF, SCNT is limited by the number of
human eggs that are available for the procedure.5z For these reasons, it is
unlikely that many researchers will use this process if stem cells are
available from other, more convenient sources.
Therefore, of all the potential sources of stem cells, the most practical
option is to use IVF embryos that were originally created to help an infertile
couple, but that the couple no longer needs.53 Stem cells derived from
excess IVF embryos have the capability of developing into any type of
human tissue, and, while destroying an IVF embryo to create a new stem cell
line is controversial, it presents less of an ethical dilemma than deriving cell
lines from aborted fetuses or cloned embryos.
"' CLONES AND CLONES: FACTS AND FANTASIES ABOUT HUMAN CLONING, supra note 21.
41 Id. Somatic cells are the cells that make up most of the body and contain two sets of
chromosomes, one set from each parent. Id. In contrast, eggs and sperm cells, which contain only a single
set of chromosomes, are called germ cells. Id.
49 id.
so Id. In 1997, a scientist in Edinburgh, Scotland announced that he had cloned a sheep by replacing
the nucleus of a sheep's egg with DNA from an adult sheep. Gina Kolata, With Cloning of a Sheep, the
Ethical Ground Shifts, N.Y. TIMES, Feb. 24, 1997, at Al. According to her creator, the sheep, born in July
1996, was named Dolly because her DNA came from a mammary gland cell "and we couldn't think of a
more impressive pair of glands than Dolly Parton's." Ian Dow, Ewe Beauty, Country Star, DAILY REC.,
Feb. 26, 1997, at 21. After developing a progressive lung disease, Dolly was put to sleep at the age of
six-approximately half of her life expectancy. Emma Ross, It's Goodbye to Dolly, Hello Questions;
Cloned Sheep Put to Death Due to Lung Disease, CHI. TRIB., Feb. 15, 2003, at 4.
51 Erik Parens, On the Ethics and Politics of Embryonic Stem Cell Research, in THE HUMAN
EMBRYONIC STEM CELL DEBATE, supra note 1, at 46.
52 Parens, supra note 51, at 46.
53 THE HUMAN EMBRYONIC STEM CELL DEBATE, supra note 1, at xvii-xviii.
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III. THE POTENTIAL FOR LIFESAVING MEDICAL ADVANCES OUTWEIGHS
ETHICAL CONCERNS OVER EMBRYONIC STEM CELL RESEARCH
Embryonic stem cell research is highly controversial because human
embryos must be destroyed in order to obtain stem cells.54 This raises
concerns among those who believe life begins at conception and that,
therefore, an embryo is a human being. 5 These individuals and groups are
staunchly opposed to any kind of research on human embryos. On the other
end of the spectrum are those who support embryonic stem cell research
because, they argue, the ends-the enormous promise of medical
advances-justify the means. While deeply-held religious beliefs contribute
to the disagreement at either end of the spectrum, many Americans beliefs
are somewhere in the middle. Ultimately, however, the promise that
embryonic stem cell research may provide the best hope for discovering
disease treatments and cures outweighs these concerns.
A. The Ethics of Embryonic Stem Cell Research-Religious Beliefs Affect
Opinions About When Life Begins
The major source of controversy surrounding embryonic stem cell
research is the unresolved question of what moral status should be accorded
to embryonic stem cells and to the embryos from which they are derived. 6
One difficulty in reaching agreement on this issue stems from the
disagreement about when human life begins.57 U.S. President George W.
Bush wrestled with this issue in 2001 when deciding whether to allow
federal funding for embryonic stem cell research.58
Beliefs in this area are often influenced by religion, and opinions
diverge not only between faiths, but also within faiths. Within the Catholic
tradition, for example, the case can be made both for and against embryonic
stem cell research.59 One point of view is that human embryos should be
given the same level of protection in research as human beings. 60 Some
5' Id. at xix.
s" Id. at xviii-xix.
56 Id. at xix.
" John A. Balint, M.D., F.R.C.P., Ethical Issues in Stem Cell Research, 65 ALB. L. REv. 729, 734
(20022. Remarks by the President, supra note 7 ("As I thought through this issue, I kept returning to two
fundamental questions: First, are these frozen embryos human life... ?").
59 Margaret A. Farley, Roman Catholic Views on Research Involving Human Embryonic Stem Cells,
in THE HUMAN EMBRYONIC STEM CELL DEBATE, supra note 1, at 115.
60 Id.
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Catholics, however, believe that an embryo at the earliest stages of
development does not yet have the "settled inherent potential to become a
human being" and need not be given the same kind of protections as a
person.6  This viewpoint is supported by embryologic studies that show
conception is a process that takes place in stages, not an instantaneous
event.
62
Other religions have a less ambivalent view on the use of embryonic
stem cells for medical research. For example, under Jewish law, an embryo
does not attain the moral status of a human being until forty days after
implantation in the uterus. 63 Because the embryos used to derive embryonic
stem cells are never implanted in a woman's uterus, they have no legal status
under Jewish law.64 The Muslim faith does not confer the legal and moral
status of a human being on a fetus until even later-at the end of the fourth
month of pregnancy. 5
B. Disagreement Over the Natural Potential of Excess IVF Embryos
Contributes to the Controversy
Setting aside religion, another focus of the debate over embryonic
stem cell research is on the natural potential for life, rather than the point at
66
which life begins. Embryonic stem cells, once derived from an embryo, no
longer have the natural potential to become a fully formed human.67
Without the outer layers of the embryo, the stem cells have lost the capacity
to create some of the structures necessary for continued development.
Some argue, therefore, that stem cells have the same moral status and should
be treated like any other type of human tissue, but not like a completely
69formed person.
The embryos from which stem cells may be derived, however, are
accorded a greater moral status under this natural potentiality analysis. 7° As
61 Id. at 115-16.
62 Id. at 115.
63 Elliot N. Dorff, Stem Cell Research - A Jewish Perspective, in THE HUMAN EMBRYONIC STEM
CELL DEBATE, supra note 1, at 91.
64 Id.
65 COMMITTEE ON THE BIOLOGICAL AND BIOMEDICAL APPLICATIONS OF STEM CELL RESEARCH, ET
AL., STEM CELLS AND THE FUTURE OF REGENERATIVE MEDICINE 44 (2002), available at
http://www.nap.edu/openbook/0309076307/htnl/index.html (last visited Nov. 6, 2003).
6 Gene Outka, The Ethics of Human Stem Cell Research, 12 KENNEDY INST. ETHICS J. 175, 188
(200227 CHAPMAN ET AL., supra note 17, at 12.
68 Id. at 3.
69 Id. at 12.
70 Outka, supra note 66.
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with all issues surrounding embryonic stem cell research, there are different
points of view on the potential of embryos to become human beings. Some
focus on the embryo's potential to become an entire human being, while
others focus on the fact that, while that capacity exists, the embryo has not
actually achieved that state 7-it is not a fully formed human being having
the same rights and owed the same ethical obligations as a person.
The nature of the IVF process is such that a large number of embryos
are created to achieve a single pregnancy, which makes excess IVF embryos
an excellent source of stem cells. Embryos created to help couples conceive
have the natural potential to become human beings. But this potential can
only be reached if the embryo is implanted in a woman's uterus and allowed
to develop. For many embryos created through IVF, however, this
potentiality will never be reached.72 IVF generally involves giving a woman
hormones to stimulate superovulation.73 This process may result in the
harvesting of ten or more eggs, all of which are usually fertilized to increase
the potential that a suitable embryo will be created.74 This process typically
results in a number of excess embryos that can be frozen for later use. 75
Excess embryos may be donated to research, destroyed, donated to other
couples, or kept frozen if a couple chooses not to use them for future
76implantation. Of these four options, only embryos donated to other
infertile couples could result in a person. The natural potential for human
life among excess embryos created for IVF is present in these embryos, but
it is highly improbable that it will ever be realized. Beliefs about an
embryo's natural potential and about religion must be balanced with the
potential for stem cell research to lead to disease treatments and cures.
C. Embryonic Stem Cell Research May Lead to New Treatments and
Cures for Many Serious Diseases
Stem cells are important to medical science because of their
regenerative potential and multipotency.77  But the pluripotency of
embryonic stem cells makes them particularly important because it gives
71 id.
72 John A. Robertson, Precommitment Strategies for Disposition of Frozen Embryos, 50 EMORY L. J.
989, 991 (2001).
73 id.
74 id.
75 id.
76 CHAPMAN ETAL., supra note 17, at 14.
77 THE HUMAN EMBRYONIC STEM CELL DEBATE, supra note 1, at xviii.
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them the ability to develop into nearly any type of cell found in the human
body.
78
The potential benefits of embryonic stem cell research are numerous.
Embryonic stem cells may be used to study the way genetic material in a
fertilized egg can create an entire organism. 79 These cells can also be used
to identify drugs and substances in the environment that cause fetal
abnormalities during a pregnancy.80  Drug toxicity testing could be
conducted using tissues created from embryonic stem cells.8 ' This would
allow for direct testing of the effects of new pharmaceuticals on human
tissues before exposing human beings to the drugs in clinical trials.
8 2
A major hope for embryonic stem cells is their potential use as a
source for clinical applications in the treatment of neurological diseases.
83
Disorders such as Parkinson's, Alzheimer's, and Lou Gehrig's disease occur
when certain types of nerve cells die.84 A mature human body cannot
replace damaged nerve cells, but embryonic stem cell research may lead to
the ability to create new nerve tissue.
5
Embryonic stem cell research may also lead to a cure for Type 1
Diabetes, the restoration of immune function in people with primary
immunodeficiency disease, and treatments for people with bone and
cartilage diseases and cancer. 6 Such dramatic possibilities illustrate why
stem cell research must be funded and supported-to maximize the potential
medical benefits they may provide.
IV. THE CURRENT U.S. APPROACHES TO REGULATING EMBRYONIC STEM
CELL RESEARCH FAIL TO ADEQUATELY ADDRESS ETHICAL CONCERNS
OR MAXIMIZE POTENTIAL MEDICAL BENEFITS
The U.S. Congress has yet to directly regulate stem cell research
through legislation, leaving the individual states free to impose their own
regulations on research. The U. S. regulates embryonic stem cell research at
the federal level by limiting federal funding for certain types of stem cell
" Id. at xvii.
79 Okarma, supra note 10, at 6.
80 Id. Currently this type of screening is done using animal models, which can only approximate
what will happen to humans. For obvious reasons, it would be unethical to conduct research in this area on
pregnant women.
"' Id. at 7.
82 id.
83 Id. at 9.
'4 CHAPMAN ET AL., supra note 17, at 5.
85 Id. at 1.
86 Id. at 5-6.
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research. Because federal grants are the main source of medical research
funding in the U. S., this approach has the practical effect of placing severe
limitations on stem cell researchers. 87  Stem cell researchers who obtain
private funds, however, are only limited by the laws of the state in which
they work.88
The federal approach has allowed the states to take various
approaches to regulating stem cell research. In 2002, California's legislature
chose the most liberal approach by adopting an act that indicated its intent to
promote stem cell research by specifically allowing research involving the
derivation and use of stem cells from any source. 89
A. The Federal Approach Results in Too Few Stem Cell Sources for
Researchers
The combination of a Congressional ban on federally-funded research
that creates new stem cell lines, President Bush's decision to severely
restrict the number of stem cell lines federally-funded researchers can work
with, and Congress' failure to directly regulate stem cell research creates a
situation in which researchers using federal funds or working at federally-
funded institutions are limited to using the handful of stem cell lines that
were in existence when President Bush made his decision.
In 1995, Congress banned federal funding for human embryo research
by attaching a rider to the Omnibus Consolidated and Emergency
Supplemental Appropriations Act ("OCESAA"), the appropriations bill that
funds the Department of Health and Human Services ("DHHS"). In January
1999, the General Counsel for DHHS issued an opinion stating that, while
derivation of embryonic stem cells is prohibited by the OCESAA rider,
research on stem cells that have already been derived is not.90 Later that
year, the National Bioethics Advisory Commission ("NBAC") issued an
executive summary on ethical issues in human stem cell research.91 Among
87 This year, the NIH expects to spend US$ 27.3 billion on medical research. Luke Timmerman,
Ban Hangs Over Decisions on Embryos, CHI. TRIB., Apr. 9, 2003, at 3B.
88 For example, California recently enacted a state law specifically permitting research on stem cells
derived from any source. CALIFORNIA HEALTH & SAFETY CODE §§ 125115-125117 (2002).
'9 S.B. 253, 2001-02 Gen. Assem., Reg. Sess. (Cal. 2001) (enacted).
90 Memorandum from Harriet S. Rabb, General Counsel, DHHS, to Harold Varns, M.D., Director,
NIH, on Federal Funding for Research Involving Human Pluripotent Stem Cells (Jan. 15, 1999), reprinted
in LORI B. ANDREWS, ET AL., GENETICS: ETHICS, LAW, AND POLICY 138 (2002) [hereinafter Rabb
Memorandum].
9' NATIONAL BIOETHICS ADVISORY COMMISSION, ETHICAL ISSUES IN HUMAN STEM CELL
RESEARCH: EXECUTIVE SUMMARY (1999) [hereinafter NBAC EXECUTIVE SUMMARY]. NBAC was
established by President Clinton to provide advice and make recommendations about the appropriateness of
"governmental programs, policies, assignments, missions, guidelines, and regulations as they relate to
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other conclusions, the NBAC summary recommended that the federal
government fund the derivation of stem cells from excess IVF embryos, as
well as research on these stem cells. 92  NBAC also recommended that
federal money not be used to fund the derivation or use of stem cells from
human embryos that were created using SCNT,93 and that DHHS establish a
National Stem Cell Oversight and Review Panel to ensure that federally-
funded research in embryonic stem cells conforms to NBAC's ethical
principles and recommendations.94
Then, in August 2000, the National Institutes of Health ("NIH"), an
agency under DHHS, published its own guidelines on 
stem cell research.95
Constrained by the rider on the OCESAA, these guidelines prohibited the
use of federal funds for derivation of new stem cell lines, but allowed
researchers to use federal grants to study new stem cell lines that were
derived, using private funding sources, from excess IVF embryos.
96 These
events all took place during the Clinton Administration.
The following year, faced with recommendations and guidelines on
embryonic stem cell research with which he did not agree, President Bush
formed a new federal policy.97 This new policy limits federally-funded stem
cell research to stem cell lines that were derived prior to August 9, 2001, the
date the president announced this new policy to the public. Congress has
attempted to formulate its own stem cell research policy through legislation,
but has yet to successfully pass a bill through both the House and the
Senate. 99
bioethical issues arising from research on human biology. Exec. Order No. 12,975, 60 Fed. Reg. 52,063
(Oct. 5, 1995).
92 NBAC EXECUTIVE SUMMARY, supra note 91, at 3.
9' Id. at 5.
94 Id. at 7.
95 NIH Guidelines for Research Using Human Pluripotent Stem Cells, 65 Fed. Reg. 51,976 (Aug. 25,
2000), corrected at 65 Fed. Reg. 69,951 (Nov. 21, 2000), withdrawn at 66 Fed. Reg. 57,107 (Nov. 14,
2001).
9' Id. § II(A)(2).
97 Remarks by the President, supra note 7.
98 Id.
99 Examples of Congressional attempts to legislate stem cell research that were never passed into law
include: Human Cloning Ban and Stem Cell Research Protection Act of 2001, S. 1893, 107th Cong. (2002);
Stem Cell Research Act of 2001, H.R. 2059, 107th Cong. (2001); Stem Cell Research Act of 2000, S. 2015,
106th Cong. (2000).
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1. The Omnibus Consolidated and Emergency Supplemental
Appropriations Act
An amendment to the OCESAA bans the use of appropriated federal
funds for research involving the creation of human embryos and for research
"in which a human embryo or embryos are destroyed, discarded, or
knowingly subjected to risk of injury or death greater than that allowed for
research on fetuses in utero."' 100 The amendment was first passed in 1995
and has been passed without change every year since then.'0 1
In response to a request from the NIH Director for a legal opinion
about whether federal funds could be used to support embryonic stem cell
research, the General Counsel for DHHS determined that, under the
OCESAA, federal funds cannot be used to create stem cell lines.'0 2 This is
because removal of the inner cell mass destroys the embryo. 10 3 However,
while federal funds cannot be used to create new stem cell lines, the General
Counsel opined that embryonic stem cells themselves are not human
embryos and, therefore, federally-funded research on existing cell lines and
privately derived cell lines is not prohibited by the OCESAA rider.'0 4
2. National Institutes of Health Guidelines on Stem Cell Research
Following the DHHS General Counsel's determination that the
OCESAA rider does not prohibit federally-funded researchers from working
on new stem cell lines that were derived without the use of federal funds,
NIH published guidelines for NIH-funded researchers because no specific
and comprehensive rules regarding federally-funded stem cell research
existed. 10
Under the guidelines, NIH funds could be used to conduct research on
pluripotent stem cells derived from human embryos, but only if the embryos
used to obtain the cells "were created for the purposes of fertility treatment
'00 Omnibus Consolidated and Emergency Supplemental Appropriations Act, Pub. L. No. 105-277,
112 Stat. 2681 (1999).
'o' Pub. L. No. 104-208, § 512, 110 Stat. 3009 (1995); Pub. L. No. 104-99, § 128, 110 Stat. 26
(1996); Pub. L. No. 105-78, § 513, 111 Stat. 1467 (1997); Pub. L. No. 105-277, § 511, 112 Stat. 2681
(1998); Pub L. No. 106-113, § 510; 113 Stat. 1501 (1999); Pub. L. No. 106-554, § 510; 114 Stat. 2763
(2000); Pub. L. No. 107-116, § 510, 115 Stat. 2177 (2001).
102 Rabb Memorandum, supra note 90.
103 id.
104 Id.
'0' NIH Guidelines for Research Using Human Pluripotent Stem Cells, 65 Fed. Reg. 51,976 (Aug. 25,
2000), corrected at 65 Fed. Reg. 69,951 (Nov. 21, 2000), withdrawn at 66 Fed. Reg. 57,107 (Nov. 14,
2001).
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and were in excess of the clinical need of the individuals seeking such
treatment."'' 0 6  This portion of the NIH guidelines complied with the
determination of the General Counsel that the OCESAA allows the use of
federal funds for research on pluripotent stem cells, but not for creating new
stem cell lines by destroying embryos.
The NIH guidelines laid out standards on financial and other
incentives for stem cell donors.'0 7  To ensure that the donation was
completely voluntary, the individuals who donated the embryos should have
received "no inducements, monetary or otherwise."10 8  Furthermore, the
fertility clinics and laboratories involved in the creation of the embryos must
have had "specific written policies and practices" in place to ensure such
inducements were not offered.10 9
NIH also called for a division between the decision to create the
embryos and the decision to donate the excess embryos for research." 0 To
ensure that potential embryo donors made the decision to donate without
pressure from a researcher who wished to derive the pluripotent stem cells,
NIH stated that the researcher interested in the stem cells must not also have
been the treating physician."'
The NIH guidelines also detailed the elements of informed consent
that must have been obtained from the embryo donors." 2 These elements
were designed to ensure that the donors understood all aspects of their
decision, including that the pluripotent stem cells might be used for human
transplantation research,' 3 that the cell lines might be kept for many
years,' 4 and that the donated embryos would not survive the pluripotent
stem cell derivation process."l5
The guidelines also specifically listed areas of research on pluripotent
stem cells that were ineligible for NIH funding." 6 These areas included
"6 Id. § II(A)(2).
107 id.
'o' Id. § II(A)(2)(a).
1o9 Id.
"0 Id. § II(A)(2)(b).
... NIH Guidelines for Research Using Human Pluripotent Stem Cells § II(A)(2)(b), 65 Fed. Reg.
51,976 (Aug. 25, 2000), corrected at 65 Fed. Reg. 69,951 (Nov. 21, 2000), withdrawn at 66 Fed. Reg.
57,107 (Nov. 14, 2001).
1' Id. § II(A)(2)(e).
... Id. § IH(A)(2)(e)(i).
"' Id. § II(A)(2)(e)(iv).
is Id. § II(A)(2)(e)(vii).
IS Id. § III.
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derivation of stem cells from human embryos, 117 research using cells derived
from sources other than excess embryos resulting from fertility treatment,"'
creation of pluripotent stem cells through SCNT,
119 and human cloning. 120
3. President Bush's Guidelines on Stem Cell Research
Dissatisfied with the Clinton Administration's recommendations and
guidelines on embryonic stem cell research, President Bush released his own
criteria for federal funding of embryonic stem cell research. 121 In a televised
address to the nation, President Bush spoke of the "widespread
disagreement" among experts and private citizens alike over whether frozen
embryos are a form of human life and whether, if they are going to be
destroyed anyway, they should instead be used for research.1 22 Referring to
embryonic stem cell research as being "at the leading edge of a series of
moral hazards" that could lead to human cloning, President Bush announced
his conclusion that federal funds could be used for embryonic stem cell
research, but only on pre-existing stem cell lines that had been created
through private research.1
23
The president's announcement limited federally-funded research on
embryonic stem cells to an estimated sixty stem cell lines in existence
"where the life and death decision [had] already been made.' 24 He also
declared his intention to name a president's council charged with monitoring
stem cell research, recommending additional guidelines, and considering the
bioethical ramifications of stem cell research and other biomedical
advances.' 25
Because the president's announcement superseded NIH's guidelines,
NIH withdrew the portion of the guidelines pertaining to human embryonic
stem cell research.
126
Ultimately, the president's announcement that about sixty available
stem cell lines met his criteria turned out to be an overestimate. 127 As of
17 NIH Guidelines for Research Using Human Pluripotent Stem Cells § Ill(A), 65 Fed. Reg. 51,976
(Aug. 25, 2000), corrected at 65 Fed. Reg. 69,951 (Nov. 21, 2000), withdrawn at 66 Fed. Reg. 57,107
(Nov. 14, 2001).
... Id. § Il1(C).
:2" Id. § III(E).
20 Id. § Ill(G).
121 Remarks by the President, supra note 7.
122 id.
123 Id.
124 id.
125 id.
126 Withdrawal of NIH Guidelines for Research Using Pluripotent Stem Cells Derived from Human
Embryos, 66 Fed. Reg. 57,107 (Nov. 14, 2001).
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November 6, 2003, more than two years after the president's announcement,
the NIH website indicated that only twelve stem cell lines meet the
announced criteria and are currently available.'
28
4. Current Bills in Congress
Congress is considering whether to regulate stem cell research in the
United States, including privately-funded research, by banning human
cloning, thus prohibiting derivation of new stem cell lines through SCNT. 
2 9
For example, the Human Cloning Prohibition Act of 2003 ("HCPA"), would
ban all forms of human cloning in the United States.' 30  The bill defines
human cloning as "human asexual reproduction, accomplished by
introducing nuclear material from one or more human somatic cells into a
fertilized or unfertilized oocyte whose nuclear material has been removed or
inactivated so as to produce a living organism (at any stage of development)
that is genetically virtually identical to an existing or previously existing
human organism."' 31 If passed, the HCPA would impact stem cell research
by making it a crime to create or attempt to create embryos through SCNT,
to use SCNT embryos to derive stem cells, and to do any research on stem
cells derived from SCNT embryos.132 This would apply to all researchers
"in or affecting interstate commerce," not just those whose research is
supported by federal funds. 33  The HCPA was passed by the House of
Representatives on February 27, 2003 and awaits Senate action.'
34
A competing bill, also introduced in the House of Representatives
would ban human cloning for reproductive purposes only. 35 It would still
allow SCNT to be performed, provided there is no attempt to initiate a
pregnancy using the clone.' 36 This would affirmatively allow research on
cloned cells, but would not alter the ban on federal funding, thus allowing
127 NIH, Human Embryonic Stem Cell Registry, at http://stemeells.nih.gov/registry (last visited Nov.
6, 2003).
128 Id. This website lists eighteen cell lines that meet the President's criteria, but six of them are not
currently available for shipping. Id. A second website lists several other stem cell lines that meet the
President's criteria but are not yet available for shipping. NIH, Human Embryonic Stem Cell Registry -
Cell Lines Not Yet Available for Shipping, at http://stemcells.nih.gov/registry/unavailable.asp (last visited
Nov. 6,2003).
29 H.R. 534, 108th Cong. (2003).
130 id.
131 Id. § 301(1).
132 Id. § 302(a).
133 Id.
134 Congressional Research Service, Bill Summary for H.R. 534, http://thomas.loc.gov/cgi-
binlbdqsery/z?d108:HR00534:@@@D&summ2=2& (last visited Dec. 19, 2003).
13 H.R. 801, 108th Cong. (2003).
136 id.
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privately-funded scientists to use SCNT to derive stem cells. It would raise
ethical concerns, however, because it would allow embryos to be cloned and
destroyed anywhere in the United States for the sole purpose of obtaining
stem cells. Similar bills have been introduced in the Senate.'
37
The federal government's approach to stem cell research has consisted
of funding restrictions, shifting administrative guidelines on research, and
failed attempts to pass legislation that would regulate stem cell research
directly. The lack of coherent federal legislation directly addressing stem
cell research has allowed the states to fill the void with their own laws. The
states have taken different approaches, with California passing the most
liberal legislation.1
38
B. California's Approach to Regulating Embryonic Stem Cell Research
Fails to Properly Address Ethical Concerns
Stem cell researchers who are funded entirely by private monies and
who do not work at federally-funded institutions are regulated only by state
law. In California, embryonic stem cell research is regulated by a law that
was passed by the California General Assembly after it found, among other
things, that the state's "public policy on stem cell research must be carefully
crafted to ensure that researchers have the tools necessary to fulfill the
promise of stem cell research."'' 39  On September 22, 2002, California
Governor Gray Davis signed Senate Bill 253, the nation's most relaxed stem
cell legislation, into law. 140 The California law declares the state's policy
"that research involving the derivation and use of human embryonic stem
cells, human embryonic germ cells, and human adult stem cells from any
source, including SCNT, shall be permitted and that full consideration of the
ethical and medical implications of this research be given."'
141
California's current law requires fertility treatment providers to
present their patients with the information necessary to decide how to
dispose of any excess embryos remaining after the fertility treatment is
completed. 142 The law further mandates that the patient "shall be presented
with the option of storing any unused embryos, donating them to another
' S. 245, 108th Cong. (2003); S. 303, 108th Cong. (2003).
138 The recently passed legislation has been codified as CALIFORNIA HEALTH & SAFETY CODE §§
125115-125117 (2002).
131 S.B. 253, 2001-02 Gen. Assem., Reg. Sess. (Cal. 2001) (enacted).
140 Mark Martin, Davis OKs Stem Cell Research / California is First State to Encourage Studies, S.F.
CHRON., Sep. 23, 2002, at Al.
'1' CAL. HEALTH & SAFETY CODE § 125115(a) (2002).
"2 CAL. HEALTH & SAFETY CODE § 125116(a) (2002).
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individual, discarding the embryos, or donating the remaining embryos for
research."' 143 The statute also requires written consent from individuals who
choose to donate excess embryos for research. 44  The second recently-
enacted law outlines the full range of options that infertility clinics must
provide to patients and their partners regarding the disposition of human
embryos.145 It also calls for the creation of an anonymous embryo registry to
provide researchers with better access to embryos that may be used for
research purposes. 146
Although the law does not appropriate any state funds for research on
embryonic stem cells and cannot alter the criteria for federally-funded
research, it may have the benefit of encouraging private funding for
embryonic stem cell research in California. 47 The law may also have the
added effect of keeping California researchers from moving to countries that
are more hospitable to stem cell research, and it may attract new researchers
to the state.'
4
In 2003, California enacted two more laws regarding stem cell
research. 149 Both of these laws become effective January 1, 2004.150 The
first of these new laws directs the California State Department of Health
Services to establish a Human Stem Cell Research Advisory Committee,
which will be charged with developing guidelines for stem cell research in
California.'15  The committee is to consist of seven scientists, two medical
ethicists, two members with backgrounds in legal issues relevant to stem cell
research, and two members with religious affiliations. 5 2  The guidelines
must be in place by January 1, 2005.'3
While the federal government takes a conservative approach to stem
cell research by limiting federally-funded stem cell researchers to
experiments on only sixteen different stem cell lines, California has chosen
'41 Id. § 125116(b). Beginning in 2004, fertility providers will be required to provide their patient
and the patient's partner with a specified list of options for disposition of excess embryos in a range of
situations. S.B. 771 (Cal. 2003). Failure to provide these options will be considered "unprofessional
conduct." S.B. 771 (Cal. 2003).
'44 CAL. HEALTH & SAFETY CODE § 125116(c). California prohibits the sale of embryonic tissue to
ensure that donation of embryos for research is voluntary. Id. § 125117.
"' S.B. 771, 2003-04 Gen. Assem., Reg. Sess. (Cal. 2003) (enacted).
14 Id.
147 Martin, supra note 140.
148 Jennifer Coleman, California Approves Research on Stem Cells, CHI. TRIB., Sept. 23, 2002, at 7.
149 Carl Ingram, Gun, Stem Cell Bills Signed; Gov. Davis Approves Measures to Make Semiautomatic
Pistols Safer and Advance Research on Serious Diseases, L.A. TIMES, Sep. 25, 2003, § 2, at 1.
ISo S.B. 771, 2002-03 Gen. Assem., Reg. Sess. (Cal. 2003) (enacted); S.B. 322, 2003-04 Gen. Assem.,
Reg. Sess. (Cal. 2003) (enacted).
"' S.B. 322, 2002-03 Gen. Assem., Reg. Sess. (Cal. 2003) (enacted).
152 Id.
153 Id.
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an extremely liberal policy that encourages privately funded researchers to
create as many new stem cell lines as possible, limited only by the
availability of raw materials. California's law allows researchers to use
excess IVF embryos to create new stem cell lines but does not require the
consent of all parties who had a stake in the creation of the embryos.'
54
Furthermore, California law allows researchers to create and destroy human
embryos solely for the purpose of deriving new stem cell lines.
V. THE TwO-TIERED AUSTRALIAN APPROACH
The Australian government has adopted an embryonic stem cell
policy that takes the middle ground between the conservative policy of the
U.S. federal government and the liberal approach of the State of California.
The Australian policy allows researchers access to a greater diversity of stem
cell lines than the U.S. federal policy, yet more closely regulates the sources
from which new stem cell lines may be derived than the California law. In
this way, Australia recognizes the important medical benefits that may result
from stem cell research, while remaining sensitive to the ethical dilemmas
presented by deriving new stem cell lines.
Australian legislation regulating stem cell research and cloning grew
out of a June 8, 2001 decision by the Council of Australian Governments
("COAG") to set a goal of achieving nationally consistent legislation
banning human cloning.' Although COAG's decisions are not binding on
154 California's original stem cell research laws required fertility providers to give the appropriate
information regarding disposition of excess embryos only to the "patient." CAL. HEALTH & SAFETY CODE
§125116(a). Beginning in 2004, fertility providers must provide this information to the patient, as well as
"the male and female partner." S.B. 771, 2003-04 Gen. Assem., Reg. Sess. (Cal. 2003) (enacted). This
appears to ensure that both members of any couple seeking fertility treatment, regardless of the couple's
sexual orientation, receive information about how they may dispose of any excess embryos. However,
once a decision to donate excess embryos has been made, the law requires the fertility provider to obtain
written consent only from "any individual who elects to donate embryos." Id. Thus, it is not clear that both
members of a couple must provide informed consent prior to donation of excess embryos for research
purposes. Furthermore, in a case where embryos are created using a donated egg or donated sperm cells,
there is no requirement that the egg or sperm donor be provided with information regarding the possible
disposition of any excess embryos created with his or her gametes.
155 COMMUNITY AFFAIRS LEGISLATION COMMITTEE OF THE AUSTRALIAN SENATE, PROVISIONS OF THE
RESEARCH INVOLVING EMBRYOS AND PROHIBITION OF HUMAN CLONING BILL 2002, 6 (2002). The Council
of Australian Governments was established in 1992 by the Prime Minister of Australia, the Premiers of the
Australian States, and the Chief Ministers of the Australian Territories. The Council of Australian
Governments (COAG), Framework, at www.dpmc.gov.au/docs/Coagframework.cfm (last visited Oct. 8,
2003). COAG exists to "initiate, develop and monitor the implementation of policy reforms which are of
national significance and which require cooperative action by Australian governments." Id.
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the Commonwealth of Australia or its states and territories, its decisions
represent the consensus reached by the member governments.
1 56
In a meeting on April 5, 2002 COAG agreed that research should only
be allowed on existing embryos that had originally been created as part of
infertility treatments and would otherwise be destroyed.157 COAG further
agreed that a strict regulatory regime should be put into place to ensure that
embryo donors gave informed consent and could restrict the types of
research to be performed on the embryos they donated.
158
As a result of the COAG decision, on June 27, 2002 the Research
Involving Embryos and Prohibition of Human Cloning bill was introduced
in Australia's House of Representatives.159 Public comment was invited
from a variety of groups and individuals including researchers, consumer
and health care groups, and ethicists.160 Following six days of spirited
debate at the end of August, 2002, the bill was split into two separate bills,
the Research Involving Embryos bill, which regulates activities involving
the use of human embryos originally created for IVF, 16' and the Prohibition
of Human Cloning bill, which bans the cloning of humans.1 62  Both bills
were passed by the Australian House of Representatives without
amendment. 
1 63
Following passage in the House, the Research Involving Embryos bill
and the Prohibition of Human Cloning bill were then introduced into the
Australian Senate in September 2002.1 4 Due to the controversial nature of
these bills, the political parties permitted Senators to vote their conscience
rather than requiring them to vote along party lines.' 65 Following over forty
156 COMMUNITY AFFAIRS LEGISLATION COMMITTEE OF THE AUSTRALIAN SENATE, supra note 155, at
7.
157 Id.
15s Id. at 6-7.
"9 Id. at 1.
160 id.
161 Research Involving Human Embryos Act, 2002, part 1, div. 3 (Austl.).
162 COMMUNITY AFFAIRS LEGISLATION COMMITTEE OF THE AUSTRALIAN SENATE, supra note 155, at
2.
163 Id
164 Id.
165 Australia Approves Stem Cell Research, THE STATE, Dec. 5, 2002, available at
http://www.thestate.com/mrld/thestate/4667412.htm?template=contentModules/printstory.jsp (last visited
Nov. 6, 2003). In the Australian Parliament votes are generally determined along party lines. But
conscience votes (also called free votes) occur when parties have made no particular decision as to how
their members should vote, usually because the parties have no particular policy on that issue or because
the matter is controversial and the parties feel their members should be able to vote their conscience.
ODGERS' AUSTRALIAN SENATE PRACTICE, 10TH ED. 249 (Harry Evans ed., 2001), available at
http://www.aph.gov.au/senate/pubs/Htmll/pdf/Chapterll.pdf (last visited Nov. 6, 2003); HOUSE OF
REPRESENTATIVES PRACTICE, 4TH ED. 277-8 (I.C. Harris ed., 2001), available at
http://www.aph.gov.au/house/pubs/PRACTICE/4Ch08.pdf (last visited Nov. 6, 2003).
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hours of debate over eleven weeks, both bills were passed in December
2002.166 They became the Research Involving Human Embryos Act
("RIHEA") and the Prohibition of Human Cloning Act ("PHCA"),
respectively. 
167
Together, RIHEA and PHCA provide researchers in Australia with a
vast source of new stem cell lines that may now be derived, with the consent
of the appropriate parties, from embryos that were originally created to help
infertile couples conceive a child. This method of regulation gives
researchers the power to create diverse stem cell lines, thus increasing the
likelihood of great medical advances, while avoiding the ethical dilemma
that arises when an embryo is created and destroyed for the purpose of
obtaining stem cells. RIHEA ensures that stem cells are only obtained from
embryos originally created for assisted reproduction after full, informed
consent is given by the parties who contributed genetic material to the
embryos with the intention of conceiving a child.
168
A. The Australian Prohibition of Human Cloning Act Prohibits
the Cloning of Human Embryos as a Source of Stem Cells for
Research
PHCA effectively prohibits the creation of human embryos for any
reason other than to achieve a pregnancy in a human female and by any
method other than fertilization of an egg by a sperm.' 69 Under PHCA, it is a
crime to intentionally create a human embryo clone, to implant a human
embryo clone in a human or animal, and to import or export a human
embryo clone.1 70  These crimes are punishable by up to fifteen years in
prison. 71 PHCA provides a legislative answer to the ethical debate over
whether it is acceptable to create embryos solely for research purposes by
prohibiting the practice altogether. This position is reinforced by RIHEA,
which outlines acceptable sources for embryonic stem cells. 1
72
166 Darren Gray, Senate Backs Use of Human Embryos in Stem Cell Research, THE AGE, Dec. 6,
2002, 2002 WL 103071091; Sandra O'Malley, Stem Cell Laws Pass Through Parliament with Little
Fanfare, AUSTRALIAN AP GEN. NEWS, Dec. 11, 2002, 2002 WL 103858390.
167 Research Involving Human Embryos Act No. 145, 2002 (Austl.). Prohibition of Human Cloning
Act, No. 144, 2002 (Austl.).
168 Research Involving Human Embryos Act, 2002, part 2, div. 1, § 9; part 2, div. 4, § 21(3)(a)
(AustIl)
I Prohibition of Human Cloning Act, 2002, part 1, § 8(1) (Austl.).
:70 Id. part 2, div. 1, §§ 9-11.
171 Id.
172 Research Involving Human Embryos Act, 2002, part 2, div. 4, § 21; part 2, div. 1, § 9 (Austl.).
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B. The Australian Research Involving Human Embryos Act Strictly
Regulates Embryonic Stem Cell Research
RIHEA addresses ethical concerns about the use of human embryos
for scientific research by regulating research involving embryos created by
assisted reproductive technology.1 73  RIHEA permits research on human
embryos originally created for use in fertility treatment but determined to be
in excess of the needs of the couple undergoing treatment.1 74 An embryo is
considered to be "excess" if the woman and her spouse have given written
consent for the embryo to be used for purposes other than fertility treatment
and they have made a written determination that the embryo is in excess of
their needs.1 75 RIHEA defines a human embryo as "a live embryo that has a
human genome or an altered human genome and that has been developing
for less than eight weeks since the appearance of two pro-nuclei or the
initiation of its development by other means."1 76 In calculating the time of
development, any time during which development is suspended, such as
when the embryo is frozen, is disregarded.1 77  RIHEA further restricts
research that may result in damage to or destruction of the embryo to
embryos created prior to April 5, 2002, the date of the COAG meeting that
lead to this legislation.
78
RIHEA also establishes a committee to determine which researchers
may use excess embryos and to ensure that their research complies with its
requirements.1 79  The Embryo Research Licensing Committee of the
National Health and Medical Research Council consists of nine members
with various and specified backgrounds. 180 These members include people
with expertise in research ethics, stem cell research, assisted reproductive
technology, law, and embryology.' 81  The licensing committee accepts
applications from researchers hoping to use excess embryos originally
created for fertility treatment. 82
173 Id. part 1, § 3 (Austl.).
174 Id. part 2, div. 4, § 21; part 2, div. 1, § 9(1) (Austl.).
... Id. part 2, div. 1, § 9(2).
176 Id. part 1, § 7(1).
177 Id. § 7(2).
178 Research Involving Human Embryos Act, 2002, part 2, div. 4, § 21(3)(b); part 2, div. 4, §
24(l)(c); part 2, div. 4, § 24(3) (Austl.). This restriction, however, is only in force until either April 5,
2005, or an earlier date, if it is declared by the Council of Australian Governments by notice in the Gazette.
Id. part 5, div. 1, § 46.
"9 Id. part 2, div. 3, § 13(1).
so Id. § 16(1).
181 Id.
"52 Id. part 2, div. 4, § 20.
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Once the licensing committee is satisfied that the researcher is in
compliance with RIHEA, it will then issue a license to perform research on
excess embryos.' 83  To meet the criteria established by RIHEA, the
researcher must have procedures in place to ensure that embryo donors have
properly consented to the embryo's use in medical research and that the
research complies with any restrictions on that consent. 84 If the research
will result in damage to or destruction of the embryo, such as when stem
cells are extracted, the embryos must have been created before April 5,
2002.185 Finally, a Human Research Ethics Committee ("HREC") must have
assessed and approved the research in compliance with the National Health
and Medical Research Council's Statement on Ethical Conduct in Research
Involving Humans.' 
86
In addition to assessing researcher compliance with these three
requirements, the licensing committee must consider other factors, including
the minimum number of embryos likely to be needed to carry out the
research and the likelihood that the research will result in a significant
advance in knowledge, or an improvement in treatments that could not
otherwise be achieved. 18 7 The licensing committee must also consider the
HREC's assessment of the project.18 8
Once the licensing committee has assessed and approved an
application, it must issue the license to the applicant and provide copies of
the license to the HREC that assessed the project and the relevant state body
in the state where the research is to take place. 8 9 The license then remains
in effect until the date specified, unless the researcher surrenders it or the
licensing committee suspends or revokes it earlier. 190 In issuing a license,
the committee may place limitations on who can use the embryos and on the
number of embryos that can be used. 19' The licensing committee can also
impose reporting and monitoring requirements. 192 The conditions of existing
licenses may be changed by the licensing committee on its own volition or at
the request of the application holder. 193
I8 ld. § 21(3).
184 Research Involving Human Embryos Act, 2002, part 2, div. 4, § 21(3)(a) (Austl.).
:'5 Id. § 21(3)(b).
186 Id. § 21(3)(c).
'ay Id. § 21(4).
Id. § 21(4).
189 Id. § 22.
190 Research Involving Human Embryos Act, 2002, part 2, div. 4, § 23 (Austl.)
'9' Id. § 24(5).
192 Id. § 24(5).
193 Id. § 25.
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The licensing committee must also create and maintain a public
database containing information on each license granted. 194 This database
must include the name of each license holder, a summary of the uses
authorized by the license, any conditions placed on the license, the number
of embryos the license holder is authorized to use, the date the license was
issued, and the length of time the license is in effect.'
95
RIHEA includes a provision requiring an independent review of the
its operation, which is to be conducted two years after its passage.
196 The
review must be undertaken concurrently with a review of PHCA. 19
7 The
review will report on developments in technology related to infertility
treatments, the potential clinical applications of developments in medical
and scientific research, community standards, and whether a national stem
cell bank should be established. 98  If the reviewers findings warrant
amendments to RIHEA, their report must recommend appropriate
revisions.
199
VI. COMPARISON OF RIHEA AND PHCA TO THE U.S. FEDERAL AND
CALIFORNIA APPROACHES
The regulations of Australia, the United States federal government,
and the State of California illustrate three different approaches to the
regulation of stem cell research. The federal government has chosen to
regulate stem cell research indirectly, by restricting the research that can be
performed with federal funds. This means that states like California can
allow researchers to create embryos for the sole purpose obtaining stem
cells, so long as they do not either directly or indirectly receive federal
research dollars. Australia, on the other hand, has passed legislation to
directly regulate stem cell research. This legislation presents a more
satisfying compromise than that reached in the United States because it
provides researchers with the opportunity to create diverse stem cell lines to
advance medical research, while ensuring that these new stem cell lines
come only from excess embryos.
19, Id. § 29.
'9' Id. § 29(1).
19 Research Involving Human Embryos Act, 2002, part 5, div. 2, § 47(1) (Austl.).
'9' Id. § 47(2).
198 Id. § 47(4).
'9 Id. § 47(5).
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A. By Permitting the Derivation of New Stem Cell Lines from Excess IVF
Embryos, the Australian Approach Provides More Sources of
Embryonic Stem Cells Than the U. S. Federal Government
The Australian legislation will likely lead to more diversity in stem
cell lines by allowing researchers to derive new lines from excess IVF
embryos. It also avoids the thornier ethical dilemma that would result from
allowing researchers to create and destroy human embryos solely to obtain
new stem cell lines.
In comparison, the United States federal govemment regulates
research on embryonic stem cells indirectly by restricting embryonic stem
cell research conducted with federal funds to that using materials from cell
lines that were created prior to August 9, 2001 "(1) with the informed
consent of the donors; (2) from excess embryos created solely for
reproductive purposes; and (3) without any financial inducements to the
donors., 200 The federal government does not regulate the sources of stem
cells used by privately-funded researchers. In contrast, Australia allows
researchers to derive new embryonic stem cell lines from donated excess
embryos originally created for fertility treatment purposes prior to April 5,
2002.201 Finally, California has the most relaxed policy of the three, which
permits research on stem cells derived from any source including embryos,
fetal tissue, and cloned adult stem cells.20 2
The federal government's approach best accommodates those who
believe life begins at conception. By allowing federal funding for only those
cell lines created prior to his announcement, President Bush limited federal
funding to research on embryonic stem cell lines "where the life and death
decision has already been made., 20 3  In contrast, the California law
permitting research on stem cells from any source caters strongly to those
who believe the scientific ends outweigh the means.
The Australian approach establishes a reasonable compromise
between the competing viewpoints. It allows for the creation of new
embryonic stem cell lines while limiting the sources of those lines to excess
embryos created for the purpose of fertility treatment. 204  Assuming,
arguendo, that these frozen embryos are a form of life, the "life or death
decision" has already been made. By definition, the "excess" embryos will
200 Fact Sheet on Embryonic Stem Cell Research, Aug. 9, 2001, available at
http://www.whitehouse.gov/news/releases/2001/08/print/20010809-1.html (last visited Nov. 6, 2003).201 Research Involving Human Embryos Act, 2002 (Austl.).
202 CAL. HEALTH & SAFETY CODE § 125115(a) (2002).
203 Remarks by the President, supra note 7.
204 Research Involving Human Embryos Act, 2002 (Austl.).
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not be implanted in the woman undergoing fertility treatment. The couple
that has sought out fertility treatment is not precluded from donating the
excess embryos to other infertile couples. But for couples who do not wish
to do this, the only other options are disposal of the embryo or indefinite
storage, neither of which result in a human life.
B. The Australian Legislative Scheme Also Provides Stronger Donor
Consent Procedures
Under the Bush Administration's policy, federally-funded research on
embryonic stem cells can only be performed on cell lines that were derived
from embryos that were donated with the informed consent of the donors.205
NIH is charged with examining the stem cell lines in existence at the time
this policy was announced and determining which lines satisfy President
Bush's criteria.2°6 Until Congress passes legislation in this area, the United
States has no nationally-consistent safeguard to ensure embryos used in
privately-funded research were obtained under appropriate informed consent
procedures. This is left open to regulation by the states.
California's new law supporting stem cell research includes measures
designed to ensure that informed consent is received from those donating
embryos for research 20 7 but these measures do not extend as far as some
ethicists recommend.20 8 California prohibits the purchase or sale of embryos
for research purposes. 209 This protects potential "donors" from coercive
financial pressures. But California's statute does nothing to ensure that
fertility providers do not, for example, create even more excess embryos
than required for fertility treatment, in an attempt to guarantee that there will
be excess embryos at the end of treatment.
A second problem with the California statute is that it does not require
the informed consent of all appropriate parties. Currently, California
requires a fertility treatment provider to give the appropriate information to
"his or her patient" so that "the individual" can make an informed decision
regarding what should be done with excess embryos after the fertility
treatment is completed. 210 Beginning in 2004, California's law will expand
to require that information on the methods of disposition of excess embryos
20' Fact Sheet on Embryonic Stem Cell Research, supra note 200.
206 id.
207 CAL. HEALTH & SAFETY CODE § 125116 (2002).
208 Donating Spare Embryos for Embryonic Stem-Cell Research, 78 FERTILITY AND STERILITY 957
(2002). CAL. HEALTH & SAFETY CODE § 125117(a) (2002).
2o Id. § 125116(a).
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211be provided to both members of any couple seeking fertility treatment.
The statute, however, does not clearly require both members of the couple to
provide informed consent prior to donating embryos for research
212purposes. In a situation where two people have made a decision to create
embryos through IVF, both should have a say in disposal of any excess
embryos. Furthermore, California law contains no provision ensuring that
individuals who donate eggs or sperm to infertile couples have the
opportunity to weigh in on the decision about how to dispose of excess
embryos, nor does the statute guarantee that they will be provided with
information regarding the potential that excess embryos created with their
gametes will be donated for research.
In contrast to the California approach, Australia provides more
extensive procedures to ensure that the appropriate informed consent is
received before an embryo is used for research purposes. PCHA guards
against coercion in the decision to donate embryos by prohibiting their
purchase and sale. 213 Violation of this provision carries a penalty of up to
ten years in prison.
RIHEA also contains stronger safeguards to ensure that informed
consent is obtained from embryo donors. A license to use excess embryos is
subject to the condition that "each responsible person in relation to the
excess ART embryo must have given proper consent to that use., 215 It
defines "responsible person" as each person who provided genetic material
for the embryo, the woman in whom the embryo would have been
implanted, and the spouses of any of these people at the time the embryo
was created.21 6 In many situations, the only responsible people who must
give consent will be the couple for whom the embryo was created in the
course of fertility treatment. But Australia recognizes that, in some cases,
unrelated egg or sperm donors may have been necessary to the creation of
the embryo and that these people may have decided against donating their
germ cells if they had known one or more of the resulting embryos might be
217used for research. Furthermore, by defining "spouse" broadly, Australia
211 S.B. 771, 2003-04 Gen. Assem., Reg. Sess. (Cal. 2003) (enacted).
212 The statute requires "any individual who elects to donate embryos" to provide written informed
consent. Id.
213 Prohibition of Human Cloning Act, 2002, part 2, div. 2, § 23 (Austl.).
214 Id.
215 Research Involving Human Embryos Act, 2002, part 2, div. 4, § 24 (Austl.). ART is an
abbreviation for Assisted Reproductive Technology.
216 Id. div. 1, § 8.
217 Samantha Maiden, Stem Cell Consent; Up to 70,000 Embryos Available, ADVERTISER, Dec. 6,
2002, at 9. The article quotes Australian Senator Kay Patterson as saying, "I think we shouldn't forget the
donors of excess embryos from IVF ... they will have the right to exercise their conscience as to whether
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ensures that unmarried partners who are living together "on a bona fide
domestic basis' '21 8 have a voice in the decision-making process. As these
people likely took an active role in deciding to participate in fertility
treatment, fairness requires that they have the opportunity to participate in
deciding how to dispose of any excess embryos.
VII. RECOMMENDATION: THE UNITED STATES SHOULD ADOPT LEGISLATION
MODELED ON AUSTRALIA'S
Of the federal, California, and Australian policies toward embryonic
stem cell research, the Australian model has achieved the best balance
between competing sides in the embryonic stem cell debate. Australia opens
up the possibility for the creation of new stem cell lines, which will give
researchers an opportunity to work with more genetically diverse material.
It limits the new sources of these stem cell lines to excess IVF embryos and
ensures that such embryos will only be donated to research with the consent
of all parties who played a part in the decision to create the embryos.
Finally, it prohibits the creation of embryos solely for the purpose of
deriving stem cells from them.
In comparison, the current policy in the United States simultaneously
offends the interests of those who support embryonic stem cell research and
those who oppose it. A large amount of biomedical research in the United
States is funded by federal money, yet researchers who use this money to
support embryonic stem cell research are restricted to the limited genetic
diversity of the few stem cell lines in existence on August 9, 2001.
Researchers who obtain private funds, however, are subject only to the
limitations imposed on them by the states. In California this means
researchers are given carte blanche to derive stem cells from any source,
including using SCNT to create embryos.
The United States should adopt legislation similar to RIHEA and
PCHA in Australia. This would allow for nationally consistent regulation of
embryonic stem cell research and would reach a compromise between those
who support such research and those who oppose it.
they will donate their embryos ...," and notes that in cases where an infertile couple creates embryos
using an egg and sperm donated by two other couples, six people would have to consent in order for the
excess embryos to be used for research purposes. Id.
2" Research Involving Human Embryos Act, 2002, part 1, § 7 (Austl.).
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VIII. CONCLUSION
Embryonic stem cell research is a controversial and divisive topic.
Divergent beliefs about the natural potential of embryos and about the moral
status that should be accorded to them are affected by strongly-held religious
beliefs, as well as secular opinions. Equally strong beliefs about the effort
that should be put into finding new treatments and cures for diseases add to
the debate. Because beliefs are so intense, it is unlikely that the controversy
over stem cell research will be completely resolved. The current approach in
the United States, however, is unsatisfactory because it severely restricts
research by limiting the projects that can be undertaken with federal funds,
while allowing states to endorse research that creates embryos for the
purpose of using-and destroying-them in research. In contrast, Australia's
approach presents a more satisfactory compromise by allowing researchers
to derive new stem cell lines from embryos created for in vitro fertilization
that would otherwise have been discarded.
